Speedier and more effective treatment of serious illnesses
15. 10. 2024
Researchers from IOCB Prague have succeeded in preparing compounds capable of activating prodrugs at predetermined locations in the body, enhancing their effectiveness and expediting their action. This will make it possible, for example, to more precisely target malignant tumours, which might greatly advance the potential of anti-cancer therapies. Compounds referred to as new-generation prodrug activators have been developed in the laboratory of Dr. Milan Vrábel, and two research articles on the matter have been published in the scientific journal Angewandte Chemie.
One objective of modern medicine is to utilize substances known as prodrugs, which are medicinal compounds that can be activated by being metabolically converted into drugs in specific parts of the body, for example near or inside cancerous tumours. It is not an easy process, because prodrugs tend to initiate their function in all sorts of places in the body. This is where compounds known as activators come into play. With their application, a specific chemical reaction is used to "unpack" the prodrug in the right location. However, the current generation of activators is slow and ineffective. Molecules of an active substance are usually released only after several hours, and the body can typically utilize only about 60% of the administered dose. Therefore, a research team at IOCB Prague, in collaboration with colleagues from the Technical University of Vienna, is working towards markedly enhancing the properties of prodrug activators.
Read the full press release on the IOCB website.
Read also
- Scholars from the Czech Academy of Sciences will help make key UN documents on refugee policy in post-communist Europe accessible
- New perspective on the climate crisis: an ERC Consolidator grant
- World first for Czech science: egg ageing can be reversed
- How the human genome duplicates. A Czech becomes a new EMBO Young Investigator
- For the First Time Ever, a Czech Scientist Wins the international Dream Chemistry Award
- AI recognises parasitic eggs better than the average ornithologist
- IOCB researchers take a key step toward fully controllable molecular machines
- Two of Europe´s most prestigious grants awarded to the Czech Academy od Sciences
- Czech scientists discover a cellular “safety switch” that protects DNA from damage
- Fungi may use toxic substances to spread skin infections from guinea pigs to children
The Czech Academy of Sciences (the CAS)
The mission of the CAS
The primary mission of the CAS is to conduct research in a broad spectrum of natural, technical and social sciences as well as humanities. This research aims to advance progress of scientific knowledge at the international level, considering, however, the specific needs of the Czech society and the national culture.
President of the CAS
Prof. Eva Zažímalová has started her second term of office in May 2021. She is a respected scientist, and a Professor of Plant Anatomy and Physiology.
She is also a part of GCSA of the EU.